Back to Search
MICHAEL TRAUNER, MD
MD
MOHS-Micrographic Surgery Physician
NPI: 1558460394Individual
Specialties, Licenses & Credentials
Dermatology Physician
Dermatology
Code: 207N00000X
A54693(CA)
MOHS-Micrographic Surgery PhysicianPrimary
Dermatology — MOHS-Micrographic Surgery
Code: 207ND0101X
A54693(CA)
Research & Publications (20)
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
PMID 18998069·Wien Med Wochenschr·2008
6-review
MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.
PMID 17295178·Semin Liver Dis·2007
6-review
Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
PMID 15758646·J Clin Gastroenterol·2005
6-review
The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: hype or hope?
PMID 15239110·Hepatology·2004
8-other
Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.
PMID 12894111·J Am Acad Dermatol·2003
5-case
Groin eruption in an HIV-positive man: epidermodysplasia verruciformis (EDV).
PMID 11939816·Arch Dermatol·2002
5-case
Nuclear receptor ligands in therapy of cholestatic liver disease.
PMID 19273351·Front Biosci (Landmark Ed)·2009
6-review
Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression.
PMID 19228884·Am J Physiol Gastrointest Liver Physiol·2009
7-preclinical
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
PMID 19475687·Hepatology·2009
7-preclinical
When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis.
PMID 19157624·J Hepatol·2009
8-other
The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice.
PMID 19585611·Hepatology·2009
7-preclinical
Nuclear receptors as therapeutic targets in cholestatic liver diseases.
PMID 19133988·Br J Pharmacol·2009
6-review
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
PMID 18812595·J Lipid Res·2009
7-preclinical
Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice.
PMID 19558576·Liver Int·2009
7-preclinical
Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-kappaB: new insights into hepatic inflammation.
PMID 18972560·Hepatology·2008
8-other
Validated comprehensive analytical method for quantification of coenzyme A activated compounds in biological tissues by online solid-phase extraction LC/MS/MS.
PMID 18613647·Anal Chem·2008
4-observational
Ischemia and cholestasis: more than (just) the bile ducts!
PMID 18431225·Transplantation·2008
7-preclinical
Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice.
PMID 18410282·Liver Int·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3641 W 5TH ST
OXNARD, CA 93030 - Phone
- (805) 985-5505
Quick Facts
- NPI
- 1558460394
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile